183.75 USD
+1.75 (+0.96%)
182.5 USD
-1.25 (-0.68%)
Overall ALAB gets a fundamental rating of 5 out of 10. We evaluated ALAB against 113 industry peers in the Semiconductors & Semiconductor Equipment industry. ALAB is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALAB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year ALAB was profitable.
- ALAB had a positive operating cash flow in the past year.
1.2 Ratios
- With an excellent Return On Assets value of 14.19%, ALAB belongs to the best of the industry, outperforming 87.61% of the companies in the same industry.
- The Return On Equity of ALAB (15.64%) is better than 79.65% of its industry peers.
- ALAB has a Return On Invested Capital of 6.48%. This is in the better half of the industry: ALAB outperforms 71.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 15.64% | ||
| ROIC | 6.48% |
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALAB has a better Profit Margin (27.50%) than 84.07% of its industry peers.
- With a decent Operating Margin value of 14.74%, ALAB is doing good in the industry, outperforming 72.57% of the companies in the same industry.
- ALAB has a better Gross Margin (75.41%) than 94.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.74% | ||
| PM (TTM) | 27.5% | ||
| GM | 75.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- ALAB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for ALAB has been increased compared to 1 year ago.
- There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- ALAB has an Altman-Z score of 144.23. This indicates that ALAB is financially healthy and has little risk of bankruptcy at the moment.
- ALAB has a Altman-Z score of 144.23. This is amongst the best in the industry. ALAB outperforms 100.00% of its industry peers.
- There is no outstanding debt for ALAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 144.23 |
ROIC/WACC0.6
WACC10.81%
2.3 Liquidity
- ALAB has a Current Ratio of 12.78. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 12.78, ALAB belongs to the top of the industry, outperforming 96.46% of the companies in the same industry.
- ALAB has a Quick Ratio of 12.27. This indicates that ALAB is financially healthy and has no problem in meeting its short term obligations.
- ALAB has a Quick ratio of 12.27. This is amongst the best in the industry. ALAB outperforms 97.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 12.78 | ||
| Quick Ratio | 12.27 |
3. Growth
3.1 Past
- ALAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -269.05%.
- Looking at the last year, ALAB shows a very strong growth in Revenue. The Revenue has grown by 242.24%.
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%
3.2 Future
- ALAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.05% yearly.
- The Revenue is expected to grow by 38.28% on average over the next years. This is a very strong growth
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue Next Year118.37%
Revenue Next 2Y77.69%
Revenue Next 3Y62.49%
Revenue Next 5Y38.28%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 112.73, the valuation of ALAB can be described as expensive.
- ALAB's Price/Earnings ratio is in line with the industry average.
- ALAB is valuated expensively when we compare the Price/Earnings ratio to 26.94, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 76.60, the valuation of ALAB can be described as expensive.
- Based on the Price/Forward Earnings ratio, ALAB is valued a bit more expensive than the industry average as 60.18% of the companies are valued more cheaply.
- The average S&P500 Price/Forward Earnings ratio is at 23.94. ALAB is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.73 | ||
| Fwd PE | 76.6 |
4.2 Price Multiples
- ALAB's Enterprise Value to EBITDA ratio is in line with the industry average.
- The rest of the industry has a similar Price/Free Cash Flow ratio as ALAB.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 135.27 | ||
| EV/EBITDA | 256.45 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ALAB's earnings are expected to grow with 48.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.39
PEG (5Y)N/A
EPS Next 2Y54.88%
EPS Next 3Y48.21%
5. Dividend
5.1 Amount
- No dividends for ALAB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
183.75
+1.75 (+0.96%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-10 2026-02-10/amc
Inst Owners76.83%
Inst Owner Change0.58%
Ins Owners11.28%
Ins Owner Change-10.29%
Market Cap31.04B
Revenue(TTM)723.04M
Net Income(TTM)198.87M
Analysts80.74
Price Target205.96 (12.09%)
Short Float %7.83%
Short Ratio2.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)28.26%
Min EPS beat(2)23.34%
Max EPS beat(2)33.19%
EPS beat(4)4
Avg EPS beat(4)27.63%
Min EPS beat(4)13.95%
Max EPS beat(4)40.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.25%
Min Revenue beat(2)9.05%
Max Revenue beat(2)9.44%
Revenue beat(4)4
Avg Revenue beat(4)7.16%
Min Revenue beat(4)2.08%
Max Revenue beat(4)9.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.01%
PT rev (3m)8.51%
EPS NQ rev (1m)0.07%
EPS NQ rev (3m)22.15%
EPS NY rev (1m)1.57%
EPS NY rev (3m)12.13%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)15.05%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)7.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.73 | ||
| Fwd PE | 76.6 | ||
| P/S | 42.92 | ||
| P/FCF | 135.27 | ||
| P/OCF | 117.67 | ||
| P/B | 24.4 | ||
| P/tB | 24.4 | ||
| EV/EBITDA | 256.45 |
EPS(TTM)1.63
EY0.89%
EPS(NY)2.4
Fwd EY1.31%
FCF(TTM)1.36
FCFY0.74%
OCF(TTM)1.56
OCFY0.85%
SpS4.28
BVpS7.53
TBVpS7.53
PEG (NY)1.39
PEG (5Y)N/A
Graham Number16.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 15.64% | ||
| ROCE | 8.2% | ||
| ROIC | 6.48% | ||
| ROICexc | 50.8% | ||
| ROICexgc | 50.8% | ||
| OM | 14.74% | ||
| PM (TTM) | 27.5% | ||
| GM | 75.41% | ||
| FCFM | 31.73% |
ROA(3y)-16.28%
ROA(5y)N/A
ROE(3y)-19.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 692.01% | ||
| Cap/Sales | 4.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 236.4% | ||
| Profit Quality | 115.38% | ||
| Current Ratio | 12.78 | ||
| Quick Ratio | 12.27 | ||
| Altman-Z | 144.23 |
F-Score8
WACC10.81%
ROIC/WACC0.6
Cap/Depr(3y)573.57%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.29%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%113.04%
EPS Next Y81.15%
EPS Next 2Y54.88%
EPS Next 3Y48.21%
EPS Next 5Y35.05%
Revenue 1Y (TTM)242.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%103.89%
Revenue Next Year118.37%
Revenue Next 2Y77.69%
Revenue Next 3Y62.49%
Revenue Next 5Y38.28%
EBIT growth 1Y-293.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year240.9%
EBIT Next 3Y91.65%
EBIT Next 5Y56.74%
FCF growth 1Y761.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1174.83%
OCF growth 3YN/A
OCF growth 5YN/A
ASTERA LABS INC / ALAB FAQ
Can you provide the ChartMill fundamental rating for ASTERA LABS INC?
ChartMill assigns a fundamental rating of 5 / 10 to ALAB.
Can you provide the valuation status for ASTERA LABS INC?
ChartMill assigns a valuation rating of 2 / 10 to ASTERA LABS INC (ALAB). This can be considered as Overvalued.
How profitable is ASTERA LABS INC (ALAB) stock?
ASTERA LABS INC (ALAB) has a profitability rating of 4 / 10.
Can you provide the financial health for ALAB stock?
The financial health rating of ASTERA LABS INC (ALAB) is 8 / 10.